Concepedia
Statistics
Publications
18
Citations
829
H-Index
16
Active since
2004
Affiliations
Abbott Fund(Current)
Abbott (United States)
AbbVie (United States)
Seoul National University
Konkuk University
Chang Park is an author at Abbott Fund specializing in drug discovery, medicinal chemistry, and pharmacy.
Publications per year
2004–2021
Structure-Guided Design of a Series of MCL-1 Inhibitors with High Affinity and Selectivity
Milan Bruncko, Le Wang, George S. Sheppard et al. · Journal of Medicinal Chemistry · 2015 · 152 citations · Full text
Pharmacy, Medicinal Chemistry, Pharmacology +14
Discovery and Design of Novel HSP90 Inhibitors Using Multiple Fragment‐based Design Strategies
Jeffrey R. Huth, Chang Park, Andrew M. Petros et al. · Chemical Biology & Drug Design · 2007 · 118 citations · Full text
SOS-NMR: A Saturation Transfer NMR-Based Method for Determining the Structures of Protein−Ligand Complexes
Philip J. Hajduk, J. Mack, Edward T. Olejniczak et al. · Journal of the American Chemical Society · 2004 · 90 citations
Pharmacy, Biophysics, Medicinal Chemistry +14
Fragment-based discovery of potent inhibitors of the anti-apoptotic MCL-1 protein
Andrew M. Petros, Steven L. Swann, Danying Song et al. · Bioorganic & Medicinal Chemistry Letters · 2014 · 80 citations · Full text
Pharmacy, Medicinal Chemistry, Pharmacology +16
Discovery and SAR of oxindole–pyridine-based protein kinase B/Akt inhibitors for treating cancers
Gui‐Dong Zhu, Viraj B. Gandhi, Jianchun Gong et al. · Bioorganic & Medicinal Chemistry Letters · 2006 · 49 citations · Full text
Pharmacy, Medicinal Chemistry, Oncology +9
1–5 of 18